Abstract:Background: Autogenous bone graft is the gold standard bone grafting substrate available in spinal fusion because of its osteoconductive, osteogenic, and osteoinductive properties. However, several shortcomings including bleeding, infection, chronic pain, and nerve injury are known to be associated with the procedure. Bone tissue engineering has emerged as an alternative therapeutic strategy for bone grafts. New materials have been developed and tested that can substitute for the autogenous bone grafts used in the spinal fusion. The purpose of this study is to evaluate the role of a novel tissue-engineered bone graft with silicon-substituted calcium phosphate (Si-CaP), autogenous fine particulate bone powder (AFPBP), and bone marrow mesenchymal stem cells (BMSCs) using a rabbit posterolateral lumbar fusion model based on bone tissue engineering principles. The application of this graft can represent a novel choice for autogenous bone to reduce the amount of autogenous bone and promote spinal fusion. Methods: BMSCs from New Zealand white rabbits were isolated and cultured in vitro. Then, BMSCs were marked by the cell tracker chloromethyl-benzamidodialkylcarbocyanine (CM-Dil). A total of 96 New Zealand White rabbits were randomly divided into four groups: (a) AFPBP, (b) Si-CaP, (c) Si-CaP/AFPBP, (d) Si-CaP/AFPBP/ BMSCs.The rabbits underwent bilateral posterolateral spine arthrodesis of the L5-L6 intertransverse processes using different grafts. Spinal fusion and bone formation were evaluated at 4, 8, and 12 weeks after surgery by manual palpation, radiology, micro-computed tomography (micro-CT), histology, and scanning electronic microscopy (SEM). Results: The rate of fusion by manual palpation was higher in the Si-CaP/AFPBP/BMSCs group than the other groups at 8 weeks. The fusion rates in the Si-CaP/AFPBP/BMSCs and the AFPBP groups both reached 100%, which was higher than the Si-CaP/AFPBP group (62.5%) (P > 0.05). No difference in bone volume was observed between the Si-CaP/AFPBP/BMSCs group (44.39%) and AFPBP group (45.06%) at 12 weeks (P < 0.05). At 12 weeks, new trabecular were visible in the Si-CaP/AFPBP/BMSCs group by SEM. CM-Dil-positive cells were observed at all stages. Compared with histological images, BMSCs participate in various stages of osteogenesis by transforming into osteoblasts, chondrocytes, and osteocytes. Conclusion: This study demonstrated for the first time that Si-CaP/AFPBP/BMSCs is a novel tissue-engineered bone graft with excellent bioactivity, biocompatibility, and biodegradability. The graft could reduce the amount of autogenous bone and promote spinal fusion in a rabbit posterolateral lumbar fusion model, representing a novel alternative to autogenous bone. The Translational potential of this article: The translational potential of this article lies in that this graft will be a novel spinal fusion graft with great potential for clinical applications.

Tissue-engineered Bone Used in a Rabbit Model of Lumbar Intertransverse Process Fusion: A Comparison of Osteogenic Capacity Between Two Different Stem Cells

A Novel Tissue-Engineered Bone Graft Composed of Silicon-Substituted Calcium Phosphate, Autogenous Fine Particulate Bone Powder and BMSCs Promotes Posterolateral Spinal Fusion in Rabbits

Posterolateral Lumbar Intertransverse Process Spine Fusion with Tissue Engineering Bone Graft in Rabbit

Construction of calcium sulfate/bone marrow mesenchymal stem cells tissue-engineered bone for spinal fusion

Spinal fusion of lumbar intertransverse process in rabbits by using bone marrow stromal stem cells in conjunction with bone morphogenetic protein with freeze-dried demineralized bone matrix as scaffold

Bone marrow mesenchymal stem cells loaded β-tricalcium phosphate promote lumbar intervertebral fusion: a randomized controlled clinical trial

Bone barrow mesenchymal stem cells in conjunction with bone morphOgenetic protein promote spine interbody fusion in rabbits

Experimental Study of Rabbit's Spinal Fusion Promoted by RGD Modified Mimetic Periosteum Combined with Nanoscale Osteoinductive Bone

Lumbar interbody spinal fusion with bone marrow stromal-derived osteoblast-calcium phosphate ceramic composites in rabbits

Tissue-engineered Bone Formation in Vivo for Artificial Laminae of the Vertebral Arch Using Β-Tricalcium Phosphate Bioceramics Seeded with Mesenchymal Stem Cells.

Chitosan-calcium phosphate/bone morphogenetic protein-2/bone marrow mesenchymal stem cells compound accelerates spinal fusion in rabbits

Enrichment of bone marrow stromal stem cells for lumbar intertransverse spinal fusion of rabbits

[Experimental Study on Spinal Fusion Induced by Hbmp-4 Gene Modified Tissue Engineered Bone].

Evaluation of Anterior Vertebral Interbody Fusion Using Osteogenic Mesenchymal Stem Cells Transplanted in Collagen Sponge

Posterolateral Spinal Fusion with Nano-Hydroxyapatite-Collagen/Pla Composite and Autologous Adipose-Derived Mesenchymal Stem Cells in A Rabbit Model

Mesenchymal Stem Cell Exosomes Enhance Posterolateral Spinal Fusion in a Rat Model

An experimental study on intertransverse process fusion promoted by mimetically osteoinductive bone in rabbits

Biomimetic vascularized adipose-derived mesenchymal stem cells bone-periosteum graft enhances angiogenesis and osteogenesis in a male rabbit spine fusion model

Experimental study on lumbar interbody fusion with silk fibroin enhanced calcium phosphate cement composite loaded with recombinant human bone morphogenetic protein-2 in sheep

Experimental Posterolateral Spinal Fusion in Rabbits with a PLGA/TCP/Col/ADSCs-OB Biomimetic Grafting Material

Low-frequency electromagnetic fields combined with tissue engineering techniques accelerate intervertebral fusion